Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries

Srisutham S. et al, (2022), PLOS ONE, 17, e0278928 - e0278928

Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia.

Rahmasari FV. et al, (2022), Malaria journal, 21

Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia

Cutts JC. et al, (2022), The Journal of Infectious Diseases, 226, 324 - 331

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878

Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers.

Kunasol C. et al, (2022), Scientific reports, 12

Reverse transcription PCR to detect low density malaria infections

Christensen P. et al, (2022), Wellcome Open Research, 6, 39 - 39

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response

Zhu L. et al, (2022), Communications Biology, 5

Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016-2017.

Das S. et al, (2022), Malaria journal, 21

Genotype-phenotype association and biochemical analyses of glucose-6-phosphate dehydrogenase variants: Implications for the hemolytic risk of using 8-aminoquinolines for radical cure.

Sudsumrit S. et al, (2022), Frontiers in pharmacology, 13

Combined effects of double mutations on catalytic activity and structural stability contribute to clinical manifestations of glucose-6-phosphate dehydrogenase deficiency.

Pakparnich P. et al, (2021), Scientific reports, 11

Genetic population of Plasmodium knowlesi during pre-malaria elimination in Thailand.

Sugaram R. et al, (2021), Malaria journal, 20

A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border

Saito M. et al, (2021), BMC Medicine, 19

Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection

Mukaka M. et al, (2021), Malaria Journal, 20

Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders

Chi PC. et al, (2021), Trials, 22

Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion

Imwong M. et al, (2021), Antimicrobial Agents and Chemotherapy, 65

Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial

McLean ARD. et al, (2021), The Lancet Infectious Diseases, 21, 1579 - 1589

Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria

Chu CS. et al, (2021), Antimicrobial Agents and Chemotherapy, 65

Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.

Hamaluba M. et al, (2021), The Lancet. Infectious diseases, 21, 1395 - 1406

Impairment of invasion and maturation and decreased selectivity of Plasmodium falciparum in G6PD Viangchan and Mahidol variants.

Palasuwan D. et al, (2021), The Journal of infectious diseases

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?